顯示所有 15 筆結果
-
Anti-CD19 [6D5] (bAb0249-BB)
-
Anti-CD20 [18B12] (bAb0185-BB)
-
Anti-CTLA-4 [9D9] (Ab01018-1.169-BB)
-
Anti-CTLA-4 [9D9] (bAb0166-BB)
-
Anti-EGFR [C225 (Cetuximab)] (bAb0163-BB)
-
Anti-EGFRvIII [L8A4] (bAb0164-BB)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (bAb0162-BB)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (bAb0183-BB)
-
Anti-F4/80 [Cl:A3-1 (recombinant version)] (bAb0184-BB)
-
Anti-Fluorescein [4-4-20 (enhanced)] (bAb0161-BB)
-
Anti-Fluorescein [4-4-20 (enhanced)] (bAb0167-BB)
-
Anti-Fluorescein [4-4-20 (enhanced)] (bAb0168-BB)
-
Anti-PD-L1 [10F.9G2] (Ab01419-1.169-BB)
-
Anti-TRP-1, gp75 [TA99] (bAb0136-BB)
-
Anti-TRP-1, gp75 [TA99] (bAb0165-BB)